top of page
MottMcDonald

Annual review 2022

Fighting drug-resistant microbes
Future-ready cities for south-east Asia

Fighting drug-resistant microbes

The rise of antimicrobial resistance (AMR) is a multipronged threat to human, animal and environmental health that demands coordinated action on a global scale. It stems from the overreliance on antimicrobial drugs in healthcare and food production. AMR reduces the effectiveness of these drugs in combating bacteria, viruses, fungi, and parasites. Mott MacDonald is the management agent for the Fleming Fund, a UK Aid programme supporting 22 countries across Asia and Africa to tackle AMR through improving surveillance. We use our expertise in development, epidemiology, microbiology and programme management to commission and manage grants in-country to collect and analyse data on drug resistance and antimicrobial use. One Health is an integrated, unifying approach to balance and optimise the health of people, animals and the environment. As a One Health programme, we support global AMR surveillance in human, veterinary and environmental health. One of our priorities is to ensure value-for-money for our client, the UK Department of Health and Social Care (DHSC). We have designed and commissioned over 80 grants investing in 240 bacteriology labs between 2016 and 2022. In each country, we design the programme to align with existing national action plans (NAPs). There have been a wide range of improvements in clinical services, equipment, biosafety and biosecurity procedures, quality assurance practices and information management systems. When AMR data is collated into a national surveillance system, it indicates the true scale of the problem and enables evidence-based policy solutions. We have seen improved antimicrobial prescribing and use as doctors, veterinarians, and other practitioners know more about the profile of drug-resistant infections. Alongside the numerous technical challenges in tackling AMR, there are a huge range of policy implications that cut across the One Health sectors − human, animal, and the environment. The Fleming Fund is helping to address this through its fellowships, supporting the professional development of AMR practitioners and influencers. We partner with universities and other institutions across the world to provide high quality mentorship and training on AMR to individuals from within national surveillance systems.

The rise of antimicrobial resistance (AMR) is a multipronged threat to human, animal and environmental health that demands coordinated action on a global scale. It stems from the overreliance on antimicrobial drugs in healthcare and food production. AMR reduces the effectiveness of these drugs in combating bacteria, viruses, fungi, and parasites.

Mott MacDonald is the management agent for the Fleming Fund, a UK Aid programme supporting 22 countries across Asia and Africa to tackle AMR through improving surveillance. We use our expertise in development, epidemiology, microbiology and programme management to commission and manage grants in-country to collect and analyse data on drug resistance and antimicrobial use. ...

Collapse

Expand

Project summary

Project

Fleming Fund

Client

UK Department of Health and Social Care (DHSC)

Location

22 priority countries across Africa and Asia

Expertise

Programme and fund management; human, animal, and environmental health; international development; capacity building; programme sustainability.

22

priority countries across Africa and Asia

240

bacteriology labs commissioned 2016-2022

Toby Leslie

Find out how we can work together

Toby Leslie

Interested in a career with us?

Thanks for submitting!

MottMcDonald

Annual review 2022

bottom of page